Screener
United Therapeutics UTHR Liabilities
Liabilities at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's liabilities?
- United Therapeutics (UTHR) reported liabilities of $819.8M in Q2 2026.
- How has United Therapeutics's liabilities changed year-over-year?
- United Therapeutics's liabilities increased by 11.6% year-over-year, from $734.4M to $819.8M.
- What is the long-term trend for United Therapeutics's liabilities?
- Over 5 years (2020 to 2025), United Therapeutics's liabilities has grown at a -8.5% compound annual growth rate (CAGR), from $1.22B to $783.8M.
- What does liabilities mean?
- Liabilities as reported by United Therapeutics Corp.
Ask your AI about United Therapeutics's liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude